Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid

被引:0
|
作者
Irja Lutsar
Ian R. Friedland
机构
[1] Pfizer Global Research & Development Ltd,Sandwich Laboratories
[2] Merck & Co. Inc.,Merck Research Laboratories
来源
Clinical Pharmacokinetics | 2000年 / 39卷
关键词
Meningitis; Cephalosporin; Ceftriaxone; Cefotaxime; Bacterial Meningitis;
D O I
暂无
中图分类号
学科分类号
摘要
Largely because of their low lipophilicity, cephalosporins poorly penetrate through the blood-brain barrier, achieving relatively low cerebrospinal fluid (CSF) concentrations. However, the minimum bactericidal concentrations (MBCs) of the extended spectrum cephalosporins for common meningeal pathogens are generally low; thus, therapeutic CSF drug concentrations several-fold greater than the MBC can be achieved with currently recommended dosage regimens. However, the effectiveness of cephalosporin therapy is unreliable in patients with meningitis caused by highly penicillin-resistant pneumococci.
引用
收藏
页码:335 / 343
页数:8
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF CEFTAZIDIME IN CEREBROSPINAL-FLUID
    DECAZES, JM
    PRESSE MEDICALE, 1988, 17 (37): : 1914 - 1916
  • [22] Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid
    Morikawa, N
    Mori, T
    Abe, T
    Ghoda, M
    Takeyama, M
    Hori, S
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (10) : 1153 - 1156
  • [23] Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir
    Martin, TM
    Morse, GD
    Kurpewski, J
    Difrancesco, R
    Caliendo, AM
    Flanigan, TP
    Tashima, KT
    AIDS, 2006, 20 (07) : 1085 - 1087
  • [24] Comment on “Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase”
    Wing H. Tong
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 919 - 920
  • [25] Comment on "Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase"
    Tong, Wing H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (05) : 919 - 920
  • [26] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS
    CRAIG, WA
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) : 89 - 96
  • [27] PHARMACOKINETICS OF ANTIMICROBIAL DRUGS IN THE CEREBROSPINAL-FLUID
    SKOPNIK, H
    HEIMANN, G
    PEDIATRIC PHARMACOLOGY, 1983, 3 (3-4): : 313 - 320
  • [28] Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets
    Abdel-Rahman, SM
    Maxson, S
    Teo, C
    Hubbard, AE
    Kearns, GL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (03): : 290 - 295
  • [29] Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid
    Capparelli, EV
    Letendre, SL
    Ellis, RJ
    Patel, P
    Holland, D
    McCutchan, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2504 - 2506
  • [30] Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves
    deCraene, BA
    Deprez, P
    DHaese, E
    Nelis, HJ
    VandenBossche, W
    DeLeenheer, AP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 1991 - 1995